Results 241 to 250 of about 211,042 (267)
Some of the next articles are maybe not open access.
Biased coin designs with a Bayesian bias
Journal of Statistical Planning and Inference, 1993zbMATH Open Web Interface contents unavailable due to conflicting licenses.
F. BALL +2 more
openaire +2 more sources
Journal of clinical anesthesia, 2020
STUDY OBJECTIVE Intranasal dexmedetomidine (DEX) can provide adequate sedation during short examinations in children. However, we found no data regarding the 95% effective dose (ED95) of intranasal DEX for children's pulmonary function testing (PFT ...
Shangyingying Li +10 more
semanticscholar +1 more source
STUDY OBJECTIVE Intranasal dexmedetomidine (DEX) can provide adequate sedation during short examinations in children. However, we found no data regarding the 95% effective dose (ED95) of intranasal DEX for children's pulmonary function testing (PFT ...
Shangyingying Li +10 more
semanticscholar +1 more source
Acta Anaesthesiologica Scandinavica, 2020
Intranasal dexmedetomidine can provide adequate sedation during short procedures. However, there are few reports investigating the effective dose of intranasal dexmedetomidine for sedation in children with congenital heart disease (CHD) before and after ...
Jing Zhang +4 more
semanticscholar +1 more source
Intranasal dexmedetomidine can provide adequate sedation during short procedures. However, there are few reports investigating the effective dose of intranasal dexmedetomidine for sedation in children with congenital heart disease (CHD) before and after ...
Jing Zhang +4 more
semanticscholar +1 more source
The power of Efron's biased coin design
Journal of Statistical Planning and Inference, 2006zbMATH Open Web Interface contents unavailable due to conflicting licenses.
openaire +2 more sources
Tests Conditional on Imbalance with Biased Coin Designs.
1986Abstract : Distributional properties of the treatment assignment variables T sub 1, ..., T sub n under Efron's (1971) biased coin design are derived. These properties are conditional on the terminal imbalance of the treatment allocation. Recursive procedures are presented for obtaining the conditional moments of T sub 1, ..., T sub n.
Edsel Pena, Myles Hollander
openaire +1 more source
An optimal response adaptive biased coin design with k heteroscedastic treatments
Journal of Statistical Planning and Inference, 2011zbMATH Open Web Interface contents unavailable due to conflicting licenses.
Gwise, Thomas E. +2 more
openaire +2 more sources
Dose Finding Using the Biased Coin Up‐and‐Down Design and Isotonic Regression
Biometrics, 2002Summary.We are interested in finding a dose that has a prespecified toxicity rate in the target population. In this article, we investigate five estimators of the target dose to be used with the up‐and‐down biased coin design (BCD) Introduced By Durham and Flournoy (1994,Statistical Decision Theory and Related Topics).These estimators are derived using
Stylianou, Mario, Flournoy, Nancy
openaire +3 more sources
On inferences from Wei's biased coin design for clinical trials
Biometrika, 1990Wei (1988) analyzed data from a clinical trial in which an urn-sampling model was used to allocate patients to treatments. The trial resulted in 11 patients being allocated to the experimental treatment, all successes, and with one patient allocated to the control treatment, a failure.
openaire +1 more source
An adaptive biased coin design for the behrens-fisher problem
Sequential Analysis, 1990Wei(1978) introduced the adaptive biased coin design to reduce experimenter bias and offer a compromise between perfect balance and complete randomization. In situations such as the Behrens-Fisher problem, balance is not necessarily desired and the optimal ratio of sample sizes is unknown.
openaire +1 more source
The adaptive accelerated biased coin design for phase I clinical trials
Journal of Applied Statistics, 2011Phase I clinical trials are designed to study several doses of the same drug in a small group of patients to determine the maximum tolerated dose (MTD), which is defined as the dose that is associated with dose-limiting toxicity (DLT) in a desired fraction Γ of patients.
Nan Jia, Thomas M. Braun
openaire +1 more source

